CARISMA Therapeutics Stock (NASDAQ: CARM) stock price, news, charts, stock research, profile.
Open | $1.23 |
Close | $1.19 |
Volume / Avg. | 638.67K / 754.52K |
Day Range | 1.15 - 1.26 |
52 Wk Range | 0.99 - 9.77 |
Market Cap | $49.85M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 4.13% |
Days to Cover | 6.59 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CARISMA Therapeutics (NASDAQ:CARM) through any online brokerage.
Other companies in CARISMA Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), HOOKIPA Pharma (NASDAQ:HOOK), Estrella Immunopharma (NASDAQ:ESLA), Barinthus Biotherapeutics (NASDAQ:BRNS) and BioLine Rx (NASDAQ:BLRX).
There is no analysis for CARISMA Therapeutics.
CARISMA Therapeutics has a consensus price target of $9.20.
The stock price for CARISMA Therapeutics (NASDAQ: CARM) is $1.2 last updated Today at July 8, 2024 at 5:54 PM EDT.
There are no upcoming dividends for CARISMA Therapeutics.
CARISMA Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for CARISMA Therapeutics.
CARISMA Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.